Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease

Neurology

Volumn 55, Issue 9, 2000, Pages 1401-1404

  Haik S ^a,g   Brandel, J P ^a   Sazdovitch, V ^a   Delasnerie Laupretre N ^a   Peoc'h, K ^f   Laplanche, J L ^f   Privat, N ^a   Duyckaerts, C ^a   Kemeny, J L ^b   Kopp, N ^c   Laquerriere A ^d   Mohr, M ^e   Deslys, J P ^g   Dormont, D ^g   Hauw, J J ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

^d HÔPITAL CHARLES NICOLLE   (France)

^e Institut de Pathologie Strasbourg   (France)

^f HÔPITAL LARIBOISIÈRE   (France)

^g DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BRAIN PROTEIN; PROTEIN 14 3 3; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC ERROR; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 0034649391     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.9.1401     Document Type: Article

References (10)

1. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
2. Diagnosis of Creutzfeldt-Jakob disease: Effect of clinical criteria on incidence estimates
3. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD
4. Report of the second dementia with Lewy bodies international workshop
5. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease
6. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies
7. Diffuse Lewy body disease: Clinical features in 15 cases
8. A case of diffuse Lewy body and Alzheimer's diseases with periodic synchronous discharges
9. EEG findings in dementia with Lewy bodies and Alzheimer's disease
10. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies